Deferiprone-induced agranulocytosis. A critical review of five rechallenged cases

Keyphrases

• Active Iron 10%
• Agranulocytosis 100%
• Bone Marrow Aspiration 10%
• Clinical Characteristics 10%
• Deferiprone 100%
• Dose Effect 20%
• First Episode 10%
• Hypochlorous Acid 10%
• Immune Defense 10%
• Immune Response 10%
• Iron Chelator 10%
• Lag Period 10%
• Myeloid Precursors 10%
• Neutropenia 30%
• Neutrophils 30%
• Orally Active 10%
• Patient Support 10%
• Re-exposure 10%
• Re-induction 10%
• Reactive Metabolites 10%
• Reactive Species 20%
• Rechallenge 30%
• Serious Adverse Effects 10%
• Severe Neutropenia 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 10%
• Agranulocytosis 100%
• Deferiprone 100%
• Hypochlorous Acid 10%
• Iron Chelating Agent 10%
• Neutropenia 40%
• Oxidizing Agent 10%